Log In
Print this Print this

Mestinon, pyridostigmine

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionOral cholinesterase inhibitor
Molecular Target Cholinesterase
Mechanism of ActionCholinesterase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMyasthenia gravis
Indication DetailsTreat myasthenia gravis (MG)
Regulatory Designation
PartnerAlliance Pharma plc;
Menarini Group;
Mylan N.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today